Session | ||
MS-09: Structure guided drug design and antibiotic resistance targets
Invited: Vibha Gupta (India), Jade Forwood (Australia) | ||
Session Abstract | ||
Structure-based drug design is a powerful tool for accelerating drug discovery. This session will cover various aspects of the method. To address the growing threats of antibiotic resistance and emergence of new viral diseases, particular emphasis will be placed on the rational design of antibacterial and antiviral drugs. For all abstracts of the session as prepared for Acta Crystallographica see PDF in Introduction, or individual abstracts below. | ||
Introduction | ||
Presentations | ||
2:45pm - 2:50pm
Introduction to session 2:50pm - 3:20pm
Understanding viral host interactions that modulate nuclear transport and innate immunity 1School of Biomedical Sciences, Charles Sturt University, Wagga Wagga, NSW, Australia; 2Center for Microbial Pathogenesis, Institute for Biomedical Sciences, Georgia State University, Atlanta, USA; 3Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, VIC, Australia; 4Australian Synchrotron, Australian Nuclear Science and Technology Organisation, 800 Blackburn Road, Clayton, VIC, Australia External Resource: https://www.xray.cz/iucrv/vidp.asp?id=66
3:20pm - 3:50pm
Novel targets in old rouges: Integrative structural biology approach for discovery of natural product inhibitors Jaypee Institute of Information Technology, A-10, Sector-62, Noida, U.P., India External Resource: https://www.xray.cz/iucrv/vidp.asp?id=67
3:50pm - 4:10pm
The structure of the ABC transporter PsaBC shows that bacterial manganese import is achieved by unique architectural features that are conserved across the kingdoms of life. 1The University of Melbourne, Parkville, Australia; 2University of Gothenburg, Gothenburg, Sweden.; 3Australian National University, Canberra, Australia; 4Kyoto University, Kyoto, Japan External Resource: https://www.xray.cz/iucrv/vidp.asp?id=68
4:10pm - 4:30pm
Uncovering the structures and mechanisms for the largest group of bacterial surface virulence factors. 1Department of Biochemistry and Genetics, La Trobe Institute for Molecular Science, La Trobe University, Melbourne, Victoria, Australia; 2Institute of Health and Biomedical Innovation, School of Biomedical Sciences, Queensland University of Technology, Herston, Queensland, Australia; 3Australian Infectious Diseases Research Centre, School of Chemistry and Molecular Biosciences, The University of Queensland, Brisbane, Queensland, Australia; 4Macromolecular Crystallography, Australian Synchrotron, Clayton, Victoria, Australia External Resource: https://www.xray.cz/iucrv/vidp.asp?id=69
4:30pm - 4:50pm
Inhibiting, stabilising and probing the function of the Retromer endosomal trafficking complex through the novel macrocyclic peptides 1The University of Queensland, Institute for Molecular Bioscience, St. Lucia, Queensland, 4072, Australia; 2The University of Queensland, School of Biomedical Sciences, St Lucia, Queensland, 4072, Australia; 3Department of Biological Sciences, Center for Structural Biology, Vanderbilt University, Nashville, TN 37232, USA; 4Cambridge Institute for Medical Research, University of Cambridge, Cambridge, UK; 5Department of Chemistry, Graduate School of Science, the University of Tokyo, 7-3-1 Hongo, Bunkyo-Ku, Tokyo 113-0033, Japan; 6Sydney Analytical, the University of Sydney, Camperdown, New South Wales 2050, Australia External Resource: https://www.xray.cz/iucrv/vidp.asp?id=70
4:50pm - 5:10pm
Structural and mechanistic studies on carbapenem-hydrolysing class D serine β-lactamases leading to improved inhibitor design 1Stanford Synchrotron Radiation Lightsource, Stanford University, Menlo Park, California, USA; 2Department of Chemistry and Biochemistry, University of Notre Dame, Notre Dame, Indiana, USA External Resource: https://www.xray.cz/iucrv/vidp.asp?id=71
|